It has been established that more than mild large-droplet macrovesicular steatosis (LD-MAS) is associated with increased risk of graft non-function. In contrast, even severe small-droplet macrovesicular steatosis (SD-MAS) has been found to be less prognostically significant. It remains unclear if a donor liver with diffuse microvesicular steatosis is associated with an increased risk of graft dysfunction. A 56-year-old male with alcoholic cirrhosis was transplanted with a liver from a 42-year-old overweight male donor after brain death. The frozen section of the donor liver biopsy taken at harvest showed diffusely enlarged clear/foamy hepatocytes and mild LD-MAS (about 5-10% of total tissue). The reperfusion liver biopsy taken at time 0 of transplantation showed hemorrhage, pale and enlarged hepatocytes, and mild LD-MAS (about 10% of total tissue) with lipopeliosis. The graft became non-functional, and the patient was re-transplanted 24 h after the initial transplantation. Histologic examination of the failed liver allograft showed extensive hemorrhagic necrosis, neutrophilic inflammation, diffuse microvesicular steatosis, and large extracellular fat droplets (about 20% of total tissue). This case demonstrates that precautions are needed to avoid using livers with diffuse and severe microvesicular steatosis.
Keyphrases
- insulin resistance
- high fat diet
- high fat diet induced
- adipose tissue
- liver injury
- low grade
- single cell
- high throughput
- drug induced
- magnetic resonance
- metabolic syndrome
- skeletal muscle
- heart failure
- type diabetes
- early onset
- acute myocardial infarction
- computed tomography
- cell therapy
- magnetic resonance imaging
- mesenchymal stem cells
- bone marrow
- ultrasound guided
- multiple sclerosis
- brain injury
- body mass index
- coronary artery disease
- functional connectivity
- atrial fibrillation
- resting state
- left ventricular
- acute ischemic stroke
- percutaneous coronary intervention
- contrast enhanced